FDAnews Device Daily Bulletin

Medical device companies looking to introduce high-risk devices in Singapore will have the option of expedited registration evaluation routes, according to a draft guideline from the Health Sciences Authority (HSA). Excluded from the new approval pathway are hip, knee and shoulder joint replacement nonbioactive implants.
International Medical Device Regulatory Monitor